Increased Histone Deacetylase Activity Involved in the Suppressed Invasion of Cancer Cells Survived from ALA-Mediated Photodynamic Treatment

Int J Mol Sci. 2015 Oct 10;16(10):23994-4010. doi: 10.3390/ijms161023994.

Abstract

Previously, we have found that cancer cells survived from 5-Aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) have abnormal mitochondrial function and suppressed cellular invasiveness. Here we report that both the mRNA expression level and enzymatic activity of histone deacetylase (HDAC) were elevated in the PDT-derived variants with dysfunctional mitochondria. The activated HDAC deacetylated histone H3 and further resulted in the reduced migration and invasion, which correlated with the reduced expression of the invasion-related genes, matrix metalloproteinase 9 (MMP9), paternally expressed gene 1 (PEG1), and miR-355, the intronic miRNA. Using chromatin immunoprecipitation, we further demonstrate the reduced amount of acetylated histone H3 on the promoter regions of MMP9 and PEG1, supporting the down-regulation of these two genes in PDT-derived variants. These results indicate that HDAC activation induced by mitochondrial dysfunction could modulate the cellular invasiveness and its related gene expression. This argument was further verified in the 51-10 cybrid cells with the 4977 bp mtDNA deletion and A375 ρ⁰ cells with depleted mitochondria. These results indicate that mitochondrial dysfunction might suppress tumor invasion through modulating histone acetylation.

Keywords: histone acetylation; histone deacetylase; invasion; metalloproteinase 9; mitochondria; paternally expressed gene 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Aminolevulinic Acid / pharmacology*
  • Azacitidine / pharmacology
  • Cell Line, Tumor
  • Cell Movement / physiology
  • Chromatin Immunoprecipitation
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylases / genetics
  • Histone Deacetylases / metabolism*
  • Histones / metabolism*
  • Humans
  • Hydroxamic Acids / pharmacology
  • Matrix Metalloproteinase 9 / biosynthesis
  • Matrix Metalloproteinase 9 / genetics
  • MicroRNAs / genetics
  • Mitochondria / pathology*
  • Neoplasm Invasiveness / pathology*
  • Photochemotherapy / methods*
  • Promoter Regions, Genetic / genetics
  • Proteins / genetics
  • Proteins / metabolism

Substances

  • Histone Deacetylase Inhibitors
  • Histones
  • Hydroxamic Acids
  • MIRN355 microRNA, human
  • MicroRNAs
  • Proteins
  • mesoderm specific transcript protein
  • trichostatin A
  • Aminolevulinic Acid
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
  • Histone Deacetylases
  • Azacitidine